Transcenta Holding Limited (06628)

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Transcenta Holding Limited (06628)

Transcenta Holding Limited, a clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People's Republic of China and the United States. The company develops TST001, a humanized claudin 18.2 mAb candidate for solid tumors, such as gastric and gastroesophageal cancer; TST808, a humanized antibody neutralizing

CS Hotline: +852 3018 4526

Trading days: 24 hours | Non-trading days: 9:00-18:00

Headquarters

Sheung Wan

Address: Room 2405-06, 24/F, 308 Central Des Voeux, Sheung Wan, Hong Kong

North District

Address: 1718-1721, Level 17 Landmark North, 39 Lung Sum Avenue, Sheung Shui, New Territories, Hong Kong

Email: cs@usmart.hk

WhatsApp: +852 5989 2641

uSMART Branches(Causeway Bay coming soon)

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907) holding Type 1 Licence for Dealing in Securities, Type 4 Licence for Advising on Securities, Type 6 Licence for Advising on Corporate Finance, and Type 9 Licence for Asset Management.

Market News

Transcenta Holding Limited (06628)

Services

About Us

Agreement Statement